Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 9
2004 7
2005 10
2006 1
2007 4
2008 5
2009 4
2010 12
2011 7
2012 7
2013 11
2014 4
2015 3
2016 5
2017 9
2018 6
2019 6
2020 2
2021 6
2022 8
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Results by year

Filters applied: . Clear all
Page 1
IFN-γ-dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis.
Garnier L, Pick R, Montorfani J, Sun M, Brighouse D, Liaudet N, Kammertoens T, Blankenstein T, Page N, Bernier-Latamani J, Tran NL, Petrova TV, Merkler D, Scheiermann C, Hugues S. Garnier L, et al. Among authors: blankenstein t. Sci Adv. 2022 Jun 10;8(23):eabl5162. doi: 10.1126/sciadv.abl5162. Epub 2022 Jun 8. Sci Adv. 2022. PMID: 35675399 Free PMC article.
[Changes to cervical cancer screening in Germany].
Starrach T, Gallwas J, Blankenstein T, Mahner S, Dannecker C. Starrach T, et al. Among authors: blankenstein t. MMW Fortschr Med. 2018 Feb;160(2):46-51. doi: 10.1007/s15006-018-0152-6. MMW Fortschr Med. 2018. PMID: 29417509 Review. German. No abstract available.
The determinants of tumour immunogenicity.
Blankenstein T, Coulie PG, Gilboa E, Jaffee EM. Blankenstein T, et al. Nat Rev Cancer. 2012 Mar 1;12(4):307-13. doi: 10.1038/nrc3246. Nat Rev Cancer. 2012. PMID: 22378190 Free PMC article. Review.
The role of CD4 T cells in rejection of solid tumors.
Poncette L, Bluhm J, Blankenstein T. Poncette L, et al. Among authors: blankenstein t. Curr Opin Immunol. 2022 Feb;74:18-24. doi: 10.1016/j.coi.2021.09.005. Epub 2021 Oct 4. Curr Opin Immunol. 2022. PMID: 34619457 Free PMC article. Review.
[Vaginal bleeding - red flags for the general practitioner].
Wagner F, Blankenstein T. Wagner F, et al. Among authors: blankenstein t. MMW Fortschr Med. 2022 Apr;164(8):56-57. doi: 10.1007/s15006-022-0923-y. MMW Fortschr Med. 2022. PMID: 35449282 Review. German. No abstract available.
CTLA4 Promotes Tyk2-STAT3-Dependent B-cell Oncogenicity.
Herrmann A, Lahtz C, Nagao T, Song JY, Chan WC, Lee H, Yue C, Look T, Mülfarth R, Li W, Jenkins K, Williams J, Budde LE, Forman S, Kwak L, Blankenstein T, Yu H. Herrmann A, et al. Among authors: blankenstein t. Cancer Res. 2017 Sep 15;77(18):5118-5128. doi: 10.1158/0008-5472.CAN-16-0342. Epub 2017 Jul 17. Cancer Res. 2017. PMID: 28716895 Free PMC article.
Receptor combinations hone T-cell therapy.
Blankenstein T. Blankenstein T. Nat Biotechnol. 2016 Apr;34(4):389-91. doi: 10.1038/nbt.3539. Nat Biotechnol. 2016. PMID: 27054992 No abstract available.
129 results